Molecular classification of the PORTEC-3 trial for high-risk endometrial cancer: Impact on adjuvant therapy

C. L. Creutzberg, A. Leon-Castillo, S. M. de Boer, M. E. Powell, L. R. Mileshkin, H. J. Mackay, A. Leary, H. W. Nijman, N. Singh, P. Pollock, A. Fyles, C. Haie-Meder, V. T. H. B. M. Smit, R. J. Edmondson, H. Putter, H. C. Kitchener, E. J. Crosbie, M. de Bruyn, R. Nout, T. Bosse

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Pages (from-to)899-900
Number of pages2
JournalAnnals of Oncology
Publication statusPublished - Oct-2019
Event44th Congress of the European-Society-for-Medical-Oncology (ESMO) - Barcelona, Spain
Duration: 27-Sept-20191-Oct-2019

Cite this